MDMA Study Finds More Than 60% Success Rate in PTSD Patients
New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.
Day: May 12, 2021
Daniel Carcillo’s Psychedelic Life Sciences Company Wesana Health Goes Public on CSE
Daniel Carcillo’s psychedelic life sciences company is now trading on the Canadian Securities Exchange.
Interview With Timothy Ko
CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.
End of content
End of content